Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Medicine 13, 265 (1 March 2007) | doi:10.1038/nm0307-265;
Unlikely partners tackle TB funding woes
Abstract
After decades of simmering silently, tuberculosis (TB) began in the early 1990s to make a deadly comeback, triggered largely by the AIDS epidemic. Drugs, diagnostics and vaccines against the disease were outdated and inadequate.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
